FDA Approved: PROLIA — Supplemental Application (Amgen, Inc)

View source ↗

Summary

The FDA has approved a supplemental application for PROLIA (denosumab) by Amgen, Inc., amending its labeling/indications.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoporosis

Drugs mentioned

• Prolia (denosumab)

Snippet

SUPPL AP for PROLIA (DENOSUMAB)